Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-14

Clinical Trial Update: Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating SMOF Lipid for the management of clozapine-induced acute poisoning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)
  • SMOF Lipid (lipid emulsion (SMOFlipid))

Snippet

Sponsor: Alexandria University | Conditions: Acute Poisoning | Phase 2 | Status: COMPLETED